Europe — EMA
Oekolp Ovula (Estriol)
GNH USA supplies Oekolp Ovula (Estriol), an estrogen for menopausal symptoms, osteoporosis prevention and vaginal atrophy. Request a quote for global supply.
Request sourcing
What is Estriol?
Estriol, the active ingredient in Oekolp Ovula, is an estrogen presented as a pharmaceutical preparation for oral use. It is employed to manage estrogen‑deficiency related conditions in postmenopausal women. GNH USA supplies Oekolp Ovula as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Estriol used for?
Estriol acts as a natural estrogen to address conditions linked to reduced endogenous hormone levels. - Menopausal vasomotor symptoms: reduces frequency and intensity of hot flashes and night sweats. - Postmenopausal osteoporosis prevention: supports bone mineral density maintenance. - Vaginal atrophy: improves dryness, irritation and dyspareunia associated with estrogen deficiency.
What are the side effects of Estriol?
Estriol may cause a range of adverse reactions, from mild to serious.
Common Side Effects: - Nausea - Headache - Breast tenderness - Fluid retention - Mild abdominal discomfort
Serious or Rare Side Effects: - Deep vein thrombosis - Pulmonary embolism - Stroke - Endometrial hyperplasia - Hepatic dysfunction
What precautions apply to Estriol?
Use estriol with careful clinical assessment and monitoring. - Assess cardiovascular risk: evaluate history of thromboembolic disease before initiating therapy. - Screen for hormone‑sensitive cancers: avoid in active breast or endometrial cancer. - Monitor liver function: adjust use if significant hepatic impairment is present. - Consider age and smoking status: higher thrombotic risk in women over 35 who smoke. - Store at ambient temperature: keep in the original container, protect from moisture and light.
What does Estriol interact with?
Estriol can interact with several drug classes, requiring vigilance.
Major Interactions (Avoid): - Oral anticoagulants: may increase risk of thrombosis. - Selective estrogen receptor modulators (e.g., tamoxifen): antagonistic hormonal effects. - Aromatase inhibitors: reduce estriol efficacy.
Moderate Interactions (Monitor Closely): - CYP450 inducers (e.g., rifampin): may lower estriol plasma levels. - Antihypertensives: fluid retention could affect blood pressure control. - Lithium: estriol may raise serum lithium concentrations.



